Can specialized HIV community pharmacies improve treatment?

©2012 Mary Ann Liebert Inc., publishers

Community pharmacies with specially trained staff to provide HIV services can help HIV-infected individuals be more compliant with their essential antiviral drug regimens and hence improve patient outcomes. Users of HIV-specialized Walgreen pharmacies across the U.S. had significantly greater adherence to and persistence with their therapeutic drug regimens according to a study published in AIDS Patient Care and STDs.

Patricia Murphy, MPH and coauthors from Walgreen Co. and University of California San Francisco School of Pharmacy compared therapeutic anti- adherence (the degree to which patients follow their prescribed drug regimen) and persistence (the time to treatment discontinuation) for HIV/AIDS patients who used HIV-specialized pharmacies or traditional community pharmacies during the time span of a year. The study, "Impact of HIV Specialized Pharmacies on Adherence and Persistence with Antiretroviral Therapy," followed patients in nine cities across seven states. The researchers propose that their results should demonstrate the value of implementing policies to encourage the use of specialized HIV pharmacies for filling antiviral prescriptions.

"While antiretroviral treatments have dramatically increased the health and life expectancy of people infected with HIV, and helped to slow HIV transmission, these medications only work if taken on a regular basis," says Editor-in-Chief Jeffrey Laurence, MD, Director of the Laboratory for Research at Weill Medical College of Cornell University, New York, NY. "Enlisting pharmacies in a multi-pronged approach to maintaining is critical. This study demonstrates the role of the pharmacist in this important endeavor."

More information: The article is available free on the AIDS Patient Care and STDs website at http://www.liebertpub.com/apc.

add to favorites email to friend print save as pdf

Related Stories

Are there gender differences in anti-HIV drug efficacy?

Aug 09, 2012

Women comprise nearly half of the HIV-infected population worldwide, but these 15.5 million women tend to be under-represented in clinical trials of anti-HIV drug therapies. The U.S. Food and Drug Administration ...

Recommended for you

Respect may be the key to stopping patient 'no shows'

1 hour ago

People with HIV are more likely to keep their scheduled medical appointments—and their disease under control—if they feel their physician listens, explains things clearly and knows them as a person, not just a "case," ...

Study details age disparities in HIV continuum of care

Jun 17, 2013

Age disparities exist in the continuum of care for patients with the human immunodeficiency virus (HIV) with people younger than 45 years less likely to be aware of their infection or to have a suppressed viral load, according ...

Cost-effective: Universal HIV testing in India

Jun 10, 2013

In India most people who are HIV positive don't know it, yet testing and treatment are relatively cheap and available. It would therefore meet international standards of cost-effectiveness—and save millions of lives for ...

User comments

More news stories

Study evaluates procedures for diagnosing sarcoidosis

Among patients with suspected stage I/II pulmonary sarcoidosis who were undergoing confirmation of the condition via tissue sampling, the use of the procedure known as endosonographic nodal aspiration compared with bronchoscopic ...